Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 7, 2011, Pages 1533-1536

  Chopra, Sidharth ^a   Matsuyama, Karen ^a   Hutson, Christopher ^a   Madrid, Peter ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

Drug repurposing; Drug resistance; Non antimicrobials; Non tuberculous mycobacteria

Indexed keywords

ACETAZOLAMIDE; ASPARTAME; BUSPIRONE; CINNARIZINE; DILTIAZEM; DOXYCYCLINE; DULOXETINE; ESTRADIOL PROPIONATE; ETHISTERONE; HYDROCORTISONE SODIUM SUCCINATE; LABETALOL; LEVOBUNOLOL; MEFEXAMIDE; MEPHENESIN; METRONIDAZOLE; MINAPRINE; NAPHAZOLINE; NATAMYCIN; NATEGLINIDE; NEOSTIGMINE; NORFLOXACIN; PRAZIQUANTEL; PUROMYCIN; RAMIPRIL; RAPAMYCIN; RESORCINOL; SULPIRIDE; UNINDEXED DRUG; XYLOMETAZOLINE; ZOMEPIRAC;

ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; NONHUMAN;

ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM;

EID: 79958804692     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr154     Document Type: Article

References (15)

1. Koul A, Arnoult E, Lounis N et al. The challenge of new drug discovery for tuberculosis. Nature 2011; 469: 483-90.
2. Lougheed KE, Taylor DL, Osborne SA et al. New anti-tuberculosis agents amongst known drugs. Tuberculosis (Edinb) 2009; 89: 364-70.
3. Antibacterial Activity and Cytotoxicity of the Prestwick 2007 Library of Compounds Against Mycobacterium tuberculosis H37Rv/Vero Cells. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1332&loc=ea_ras (8 November 2010, date last accessed).
4. Griffith DE, Aksamit T, Brown-Elliot BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
5. Bastian S, Brossier F, Wichlacz C et al. Daptomycin is not active against rapidly growing mycobacteria. J Med Microbiol 2010; 59: 135-6.
6. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes: Approved tandard M24-A. NCCLS, Wayne, PA, USA, 2003.
7. Stover CK, Warrener P, VanDevanter DR et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 2000; 405: 962-6.
8. Boselli E, Guillier M, Freney J et al. Antibacterial activity of clonidine and neostigmine in vitro. Anesth Analg 2005; 101: 121-4.
9. Cavicchioli M, Leite CQ, Sato DN et al. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes. Arch Pharm (Weinheim) 2007; 340: 538-42.
10. Gayathri R, Therese KL, Deepa P et al. Antibiotic susceptibility pattern of rapidly growing mycobacteria. J Postgrad Med 2010; 56: 76-8.
11. Mohamed GG, Soliman MH. Synthesis, spectroscopic and thermal characterization of sulpiride complexes of iron, manganese, copper, cobalt, nickel, and zinc salts. Antibacterial and antifungal activity. Spectrochim Acta A Mol Biomol Spectrosc 2010; 76: 341-7.
12. Karakurt A, Ozalp M, Işik S et al. Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives. Bioorg Med Chem 2010; 18: 2902-11.
13. Boguski MS, Mandl KD, Sukhatme VP. Drug discovery. Repurposing with a difference. Science 2009; 324: 1394-5.
14. Minakuchi T, Nishimori I, Vullo D et al. Molecular cloning, characterization, and inhibition studies of the Rv1284 b-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem 2009; 52: 2226-32.
15. Wallace RJ Jr, Brown-Elliott BA, Crist CJ et al. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46: 3164-7.